As Artificial Intelligence becomes more popular in everyday life, drug research and development companies are incorporating ...

Charles River Laboratories, a leading provider of preclinical drug development services, has reported impressive results in ...

Drug development describes the process of developing a new drug that effectively targets a specific weakness in a cell. This process involves specific pre-clinical development and testing ...

Makers of organoids and cell models cheered the decision and said it will bolster the development of precision medicines, ...

High-ranking OpenAI employees have met with the FDA multiple times in recent weeks to discuss AI and a project called cderGPT ...

The transition from preclinical development to clinical trials is a critical, with approximately 89% of drugs failing. Nearly half of these failures stem from unexpected and unmanageable human ...

Columbia University, the Company’s collaboration partner for pre-clinical development, granted Silo an exclusive global license to further develop, manufacture, and commercialize SPC-15 worldwide.

AI business Recursion Pharmaceuticals has narrowed its drug development ... Recursion is pausing development of REC-4539, a clinical-stage oncology candidate. A preclinical programme in an ...